Adzenys XR-ODT
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
70165-020 -
Package NDC
70165-020-30 -
Package NDC
70165-020-31 -
Application number
NDA204326 -
SPL ID
51b6449e-77c9-3dac-e063-6294a90aaeb6 -
SPL set ID
c1179269-00b5-48ea-972d-31e614e99b7e -
UNII
CK833KGX7E -
RxCUI
1739803 -
RxCUI
1739809 -
RxCUI
1739813 -
RxCUI
1739815 -
RxCUI
1739819 -
RxCUI
1739821 -
RxCUI
1739825 -
RxCUI
1739827 -
RxCUI
1739831 -
RxCUI
1739833 -
RxCUI
1739837 -
RxCUI
1739839
What the source publishes
- Labeler
- Neos Therapeutics Brands, LLC
- Active ingredients
- Amphetamine
- Form
- TABLET, ORALLY DISINTEGRATING
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- NDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Adzenys XR-ODT",
"splId": "51b6449e-77c9-3dac-e063-6294a90aaeb6",
"labels": [
{
"setId": "c1179269-00b5-48ea-972d-31e614e99b7e",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c1179269-00b5-48ea-972d-31e614e99b7e",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c1179269-00b5-48ea-972d-31e614e99b7e"
}
],
"routes": [
"ORAL"
],
"labeler": "Neos Therapeutics Brands, LLC",
"finished": true,
"packaging": [
{
"sample": false,
"description": "30 BLISTER PACK in 1 CARTON (70165-020-30) / 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK",
"package_ndc": "70165-020-30",
"identifierStatus": "well-formed",
"marketing_start_date": "20160216"
},
{
"sample": false,
"description": "30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (70165-020-31)",
"package_ndc": "70165-020-31",
"identifierStatus": "well-formed",
"marketing_start_date": "20261001"
}
],
"productId": "70165-020_51b6449e-77c9-3dac-e063-6294a90aaeb6",
"useDomain": "unknown",
"dosageForm": "TABLET, ORALLY DISINTEGRATING",
"productNdc": "70165-020",
"deaSchedule": "CII",
"genericName": "Amphetamine",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "AMPHETAMINE",
"strength": "12.5 mg/1"
}
],
"applicationNumber": "NDA204326",
"marketingCategory": "NDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20160216",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000175739",
"N0000175729"
],
"upc": [
"0370165025317",
"0370165015301",
"0370165005319",
"0370165010306",
"0370165030311",
"0370165020312",
"0370165030304",
"0370165005302",
"0370165015318",
"0370165025300",
"0370165020305",
"0370165010313"
],
"unii": [
"CK833KGX7E"
],
"rxcui": [
"1739803",
"1739809",
"1739813",
"1739815",
"1739819",
"1739821",
"1739825",
"1739827",
"1739831",
"1739833",
"1739837",
"1739839"
],
"spl_set_id": [
"c1179269-00b5-48ea-972d-31e614e99b7e"
],
"pharm_class_pe": [
"Central Nervous System Stimulation [PE]"
],
"pharm_class_epc": [
"Central Nervous System Stimulant [EPC]"
],
"manufacturer_name": [
"Neos Therapeutics Brands, LLC"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:70165-020_51b6449e-77c9-3dac-e063-6294a90aaeb6"